当前位置:产品中心 > 抗体 > ADC类抗体 > Anti-SLC39A6-MMAE ADC(Dar4)[Ladiratuzumab vedotin]
Anti-SLC39A6-MMAE ADC(Dar4)[Ladiratuzumab vedotin]
基本信息

产品编号:GM-81144AB

产品名称:Anti-SLC39A6-MMAE ADC(Dar4)[Ladiratuzumab vedotin]

目录价:询价


产品配图.jpg

规格货号

GM-81144AB-100        100μg

GM-81144AB-1mg       1mg

产品简介

Expression System                               CHO

Aggregation                                         < 5% as determined by SEC-HPLC

Purity                                                    >95% as determined by SDS-PAGE

Drug-to-Antibody Ratio (DAR)           4.0

Endotoxin                                             <1 EU/mg, determined by LAL gel clotting assay

Sterility                                                  0.22 μm Filtered

Target                                                    SLC39A6

Clone                                                     Ladiratuzumab vedotin

Alternative Names                               SGN-LIV1A; Anti-LIV-1 ADC

Source / Isotype                                   Human IgG1(KDEL), kappa

Application                                           Positive control of Cytotoxicity Assay

Description                                           Ladiratuzumab vedotin, also known as SGN-LIV1A and anti-LIV-1 ADC, is a humanized antibody conjugated through a proteolytically cleavable linker to MMAE to Zinc transporter LIV-1 (SLC39A6).

Formulation                                          20 mM Histidine, pH 6.0

Storage temp.                                       Store at +4°C short term. Store at -80°C for 36 months, avoiding freeze/thaw cycles.

数据展示

GM-81144AB-1.png


/ueditor/image/20240527/1716778700063594/d7e5efc7552febf4bde0118749cc3c14.png


/ueditor/image/20240527/1716778724839918/72b7115ad9e1cea21772b909ab455e6e.png

当前位置:产品中心 > 抗体 > ADC类抗体 > Anti-SLC39A6-MMAE ADC(Dar4)[Ladiratuzumab vedotin]

Anti-SLC39A6-MMAE ADC(Dar4)[Ladiratuzumab vedotin]
基本信息

产品编号:GM-81144AB

产品名称:Anti-SLC39A6-MMAE ADC(Dar4)[Ladiratuzumab vedotin]

目录价:询价


产品配图.jpg

规格货号

GM-81144AB-100        100μg

GM-81144AB-1mg       1mg

产品简介

Expression System                               CHO

Aggregation                                         < 5% as determined by SEC-HPLC

Purity                                                    >95% as determined by SDS-PAGE

Drug-to-Antibody Ratio (DAR)           4.0

Endotoxin                                             <1 EU/mg, determined by LAL gel clotting assay

Sterility                                                  0.22 μm Filtered

Target                                                    SLC39A6

Clone                                                     Ladiratuzumab vedotin

Alternative Names                               SGN-LIV1A; Anti-LIV-1 ADC

Source / Isotype                                   Human IgG1(KDEL), kappa

Application                                           Positive control of Cytotoxicity Assay

Description                                           Ladiratuzumab vedotin, also known as SGN-LIV1A and anti-LIV-1 ADC, is a humanized antibody conjugated through a proteolytically cleavable linker to MMAE to Zinc transporter LIV-1 (SLC39A6).

Formulation                                          20 mM Histidine, pH 6.0

Storage temp.                                       Store at +4°C short term. Store at -80°C for 36 months, avoiding freeze/thaw cycles.

数据展示

GM-81144AB-1.png


/ueditor/image/20240527/1716778700063594/d7e5efc7552febf4bde0118749cc3c14.png


/ueditor/image/20240527/1716778724839918/72b7115ad9e1cea21772b909ab455e6e.png

Tel: 400-627-9288
留言咨询
重置
提交
客服
微信
电话
留言
留言咨询
重置
提交